60% of high-priority research goes unfunded.
Select the text below and copy the link.
We thank the following corporate partners who recognize that cancer is truly everyone’s business.
Dr Perreault identified new molecules that may help make immunotherapies work for more people.
Last year CCS funded $40 million in cancer research, thanks to our donors. Discover how you can help reduce the burden of cancer.
Monday to Friday